Single Cell Discoveries

🤝We are the only transcriptomics CRO built to deliver high-quality data quickly and reliably. Our team identifies the right workflow for your research and runs single-cell, bulk, and spatial RNA sequencing projects end to end. You receive fully analyzed data within four weeks, with no uncertainty about timelines or outcomes. Learn more about our services on our website!

Single Cell Discoveries acts as a thought partner, not just a service provider. We help shape experimental design, make trade-offs explicit, and align work with downstream objectives. This approach supports complex, multi-phase programs where confidence and consistency matter.

🤝 At Single Cell Discoveries, we continuously evaluate new platforms through internal R&D and real-world validation. We adopt technologies only when they clearly improve data quality, robustness, or interpretability. When commercial options fall short, we build and validate proprietary assays and workflows. Partner with us to receive tailored advice for your biological question.

🥇At Single Cell Discoveries, we specialize in delivering high-impact insights through advanced single-cell technologies. With experience spanning 50+ organisms and 30+ tissue types, our team ensures reliable data for informed decision-making.

Toxicology testing is changing. It is no longer limited to visible cell damage or basic viability assays. With Discovery-seq, our high-throughput RNA sequencing service, you can detect early molecular signs of toxicity across thousands of samples. By measuring genome-wide expression changes, Discovery-seq helps you understand how a compound affects key pathways such as stress response and apoptosis, even before toxicity becomes visible. Read the case study that demonstrates how Discovery-seq can show additive drug treatment effects!

Large-scale toxicology studies often require analyzing hundreds or thousands of conditions, doses, or compounds. Traditional RNA sequencing methods can make this process slow and costly. Discovery-seq changes that. It is an automated, high-throughput workflow that delivers bulk RNA sequencing data from thousands of samples, with reduced bias and improved sensitivity. You can assess transcriptomic responses to small molecules, siRNAs, or CRISPR edits all in a single, efficient experiment. Download our tech note to access the case study on how Discovery-seq uncovers additive drug treatment effects.